Sicagen Intrinsic Value
SICAGEN Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹49.92 | ₹39.94 - ₹59.90 | -10.6% | EPS: ₹4.16, Sector P/E: 12x |
| Book Value Method | asset | ₹121.00 | ₹108.90 - ₹133.10 | +116.7% | Book Value/Share: ₹121.00, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹111.66 | ₹100.49 - ₹122.83 | +100.0% | Revenue/Share: ₹229.00, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹66.00 | ₹59.40 - ₹72.60 | +18.2% | EBITDA: ₹44.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹73.32 | ₹58.66 - ₹87.98 | +31.3% | CF Growth: 3.1%, Discount: 15% |
| PEG Ratio Method | growth | ₹26.62 | ₹23.96 - ₹29.28 | -52.3% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹34.28 | ₹30.85 - ₹37.71 | -38.6% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| Graham Defensive Method | conservative | ₹106.42 | ₹95.78 - ₹117.06 | +90.6% | EPS: ₹4.16, BVPS: ₹121.00 |
Want to compare with current market value? Check SICAGEN share price latest .
Valuation Comparison Chart
SICAGEN Intrinsic Value Analysis
What is the intrinsic value of SICAGEN?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Sicagen (SICAGEN) is ₹73.32 (median value). With the current market price of ₹55.83, this represents a +31.3% variance from our estimated fair value.
The valuation range spans from ₹26.62 to ₹121.00, indicating ₹26.62 - ₹121.00.
Is SICAGEN undervalued or overvalued?
Based on our multi-method analysis, Sicagen (SICAGEN) appears to be trading below calculated value by approximately 31.3%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 27.83 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 1.49 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 3.3% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 4.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.27x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
Related Pages for Sicagen
Additional stock information and data for SICAGEN
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹34 Cr | ₹27 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹25 Cr | ₹24 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹15 Cr | ₹13 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹-2 Cr | ₹-2 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹31 Cr | ₹23 Cr | Positive Free Cash Flow | 8/10 |